aod9604 wada banned World Anti-Doping Agency (WADA) Prohibited List WADA just added tirzepatide (mounjaro)

The paper is Awosemo et al

For a large portion of the population, that conversion simply doesnt happen efficiently

The researchers concluded that AOD9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, zero serious adverse events were attributed to the peptide, and no participants withdrew due to treatment-related effects

At Perfect B in Doral, FL, we are currently in an internal evaluation phase with AOD 9604

ClinicalTrials.gov (2026) Related Dosing Protocols Educational use only This guide is an educational research reference, not medical advice or a treatment plan